Fig. 2From: Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocolOverview of procedures for main study and patient reported outcomes (PRO) sub-studyBack to article page